This podcast episode addresses the diagnosis of hepatorenal syndrome (HRS), emphasizing that it should be viewed as AKI on portal hypertension rather than merely AKI in a patient with cirrhosis. The discussion highlights the hormonal changes and vasodilation that occur due to portal hypertension, leading to vasoconstriction in the kidneys. A key point is the shift in diagnostic approach, moving away from a rigid checklist to diagnosing HRS by excluding other potential causes, such as pre-renal issues, ATN, or glomerular nephritis. Serum and urine sodium levels, particularly a FENA less than 0.1%, are crucial indicators, even when patients are on diuretics. The necessity of a 48-hour albumin challenge is also questioned, with experts suggesting it's not mandatory and should be based on the patient's volume status.
Sign in to continue reading, translating and more.
Continue